We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Lipid Blood Test Identifies Children at Risk of Diabetes

By LabMedica International staff writers
Posted on 20 Feb 2025

Lipids have traditionally been considered as fatty acids in the body, including the different types of cholesterol or triglycerides, which are fats found in the bloodstream and are the most common in the human body. More...

Recent research has revealed a new connection between lipids and metabolic disorders in children, offering potential for early detection of conditions like liver disease.

A team of researchers from King's College London (London, UK) has developed an innovative blood test that utilizes lipids to identify children who may be more vulnerable to obesity-related health issues, including type 2 diabetes, liver disease, and heart disease. Current techniques, such as mass spectrometry, are used to estimate the thousands of different lipids in the body, with each lipid serving a specific function. For their study, the team examined blood samples from a control group of 1,300 children with obesity and analyzed their lipid profiles. Subsequently, 200 of these children participated in the HOLBAEK lifestyle intervention program, a widely used approach in Denmark for addressing obesity. Follow-up readings indicated that, despite limited improvements in the children's body mass index (BMI), lipid levels associated with diabetes risk, insulin resistance, and blood pressure decreased in the intervention group.

The research uncovered new lipid molecules that contribute to health risks like elevated blood pressure, showing that these lipids are not only linked to a child's weight. The researchers suggest that blood plasma testing machines, which are already in use in hospitals, could help healthcare providers quickly identify early indicators of disease in children and provide timely access to the appropriate treatment. Their findings, published in Nature Medicine, also challenge the widely held belief that cholesterol is the primary factor in obesity-related complications in children. While obesity remains a significant risk factor for conditions such as fatty liver disease, the team hopes that these lipid measurements will help doctors treat children when they are at risk, not just when they are slightly overweight compared to their peers.

"For decades, scientists have relied on a classification system for lipids that have split them into good and bad cholesterol, but now with a simple blood test we can assess a much broader range of lipid molecules that could serve as vital early warning signs for illness,” said Dr. Cristina Legido-Quigley, a group leader in Systems Medicine at King's College London, Head of Systems Medicine at the Steno Diabetes Centre Copenhagen (SDCC) and principal author. “In the future, this has the potential to be an entirely new way to evaluate someone's personal risk of disease. By studying how to change lipid molecules in the body, we could even prevent metabolic diseases like diabetes altogether."


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Serological Pipet Controller
PIPETBOY GENIUS
New
Plasmodium Test
Plasmodium DNA Real Time PCR Kit
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.